Filippos Vingopoulos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myopia | 4 | 2021 | 254 | 1.960 |
Why?
|
Photorefractive Keratectomy | 3 | 2022 | 38 | 1.660 |
Why?
|
Keratomileusis, Laser In Situ | 3 | 2021 | 88 | 1.580 |
Why?
|
Refraction, Ocular | 3 | 2021 | 182 | 1.420 |
Why?
|
Fluorescein Angiography | 7 | 2023 | 940 | 0.970 |
Why?
|
Retinal Vein Occlusion | 5 | 2023 | 137 | 0.940 |
Why?
|
Lasers, Excimer | 3 | 2021 | 72 | 0.930 |
Why?
|
Visual Acuity | 12 | 2022 | 2530 | 0.910 |
Why?
|
Tomography, Optical Coherence | 12 | 2023 | 2657 | 0.900 |
Why?
|
Keratoconus | 2 | 2022 | 121 | 0.870 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2022 | 27 | 0.820 |
Why?
|
Contrast Sensitivity | 7 | 2023 | 244 | 0.760 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2020 | 19 | 0.740 |
Why?
|
Sclera | 1 | 2021 | 200 | 0.720 |
Why?
|
Lenses, Intraocular | 1 | 2021 | 140 | 0.700 |
Why?
|
Lens Implantation, Intraocular | 1 | 2021 | 192 | 0.690 |
Why?
|
Choroid | 2 | 2021 | 322 | 0.680 |
Why?
|
Astigmatism | 1 | 2019 | 69 | 0.660 |
Why?
|
Photochemotherapy | 2 | 2022 | 807 | 0.630 |
Why?
|
Corneal Topography | 4 | 2022 | 69 | 0.620 |
Why?
|
Suture Techniques | 1 | 2021 | 798 | 0.550 |
Why?
|
Cornea | 2 | 2022 | 1524 | 0.510 |
Why?
|
Macula Lutea | 2 | 2023 | 151 | 0.390 |
Why?
|
Cross-Linking Reagents | 2 | 2022 | 694 | 0.300 |
Why?
|
Corneal Stroma | 3 | 2021 | 174 | 0.270 |
Why?
|
Fundus Oculi | 3 | 2023 | 473 | 0.260 |
Why?
|
Riboflavin | 2 | 2022 | 108 | 0.240 |
Why?
|
Retinal Diseases | 2 | 2021 | 684 | 0.230 |
Why?
|
Vision Tests | 1 | 2023 | 167 | 0.220 |
Why?
|
Epiretinal Membrane | 1 | 2022 | 68 | 0.210 |
Why?
|
Microscopy, Acoustic | 1 | 2021 | 45 | 0.200 |
Why?
|
Retinal Vein | 1 | 2021 | 47 | 0.190 |
Why?
|
Prospective Studies | 10 | 2021 | 53290 | 0.190 |
Why?
|
Photosensitizing Agents | 2 | 2022 | 602 | 0.180 |
Why?
|
Retinal Artery | 1 | 2021 | 111 | 0.180 |
Why?
|
Twins, Monozygotic | 1 | 2022 | 458 | 0.180 |
Why?
|
Bowman Membrane | 1 | 2019 | 2 | 0.180 |
Why?
|
Ultraviolet Rays | 2 | 2022 | 1060 | 0.170 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.170 |
Why?
|
Retinal Vessels | 2 | 2023 | 772 | 0.160 |
Why?
|
Vision, Ocular | 1 | 2022 | 464 | 0.160 |
Why?
|
Blepharoptosis | 1 | 2019 | 143 | 0.160 |
Why?
|
Pregnancy | 1 | 2020 | 29144 | 0.160 |
Why?
|
Scotoma | 1 | 2019 | 139 | 0.150 |
Why?
|
Lacrimal Apparatus | 1 | 2019 | 225 | 0.150 |
Why?
|
Presenilin-1 | 1 | 2021 | 635 | 0.150 |
Why?
|
Epithelium, Corneal | 1 | 2020 | 247 | 0.150 |
Why?
|
Optic Disk | 1 | 2020 | 400 | 0.140 |
Why?
|
Vision Disorders | 1 | 2022 | 1058 | 0.120 |
Why?
|
Dry Eye Syndromes | 1 | 2019 | 386 | 0.120 |
Why?
|
Prosthesis Design | 1 | 2021 | 2110 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2021 | 980 | 0.110 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.110 |
Why?
|
Combined Modality Therapy | 2 | 2022 | 8642 | 0.110 |
Why?
|
Diabetic Retinopathy | 1 | 2020 | 1210 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1018 | 0.100 |
Why?
|
Learning | 1 | 2020 | 1711 | 0.090 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39052 | 0.090 |
Why?
|
Humans | 21 | 2023 | 744366 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1643 | 0.080 |
Why?
|
Retrospective Studies | 6 | 2023 | 77460 | 0.080 |
Why?
|
Retina | 3 | 2023 | 2616 | 0.070 |
Why?
|
Female | 10 | 2021 | 380193 | 0.070 |
Why?
|
Adult | 5 | 2021 | 214052 | 0.060 |
Why?
|
Male | 8 | 2022 | 350115 | 0.060 |
Why?
|
Young Adult | 2 | 2020 | 56429 | 0.060 |
Why?
|
Colombia | 1 | 2021 | 258 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8038 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1639 | 0.040 |
Why?
|
Photography | 1 | 2021 | 520 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25039 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15297 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 85779 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29786 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
Aged | 3 | 2021 | 163288 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3270 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1461 | 0.030 |
Why?
|
Collagen | 1 | 2019 | 2688 | 0.020 |
Why?
|
Middle Aged | 5 | 2020 | 213390 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9312 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15078 | 0.020 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16367 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21748 | 0.010 |
Why?
|
Child | 2 | 2019 | 77709 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|